IBDEI1MA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27437,1,4,0)
 ;;=4^T86.13
 ;;^UTILITY(U,$J,358.3,27437,2)
 ;;=^5055711
 ;;^UTILITY(U,$J,358.3,27438,0)
 ;;=Z94.0^^106^1359^8
 ;;^UTILITY(U,$J,358.3,27438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27438,1,3,0)
 ;;=3^Kidney Transplant Status
 ;;^UTILITY(U,$J,358.3,27438,1,4,0)
 ;;=4^Z94.0
 ;;^UTILITY(U,$J,358.3,27438,2)
 ;;=^5063654
 ;;^UTILITY(U,$J,358.3,27439,0)
 ;;=Z48.22^^106^1359^1
 ;;^UTILITY(U,$J,358.3,27439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27439,1,3,0)
 ;;=3^Aftercare Following Kidney Transplant
 ;;^UTILITY(U,$J,358.3,27439,1,4,0)
 ;;=4^Z48.22
 ;;^UTILITY(U,$J,358.3,27439,2)
 ;;=^5063039
 ;;^UTILITY(U,$J,358.3,27440,0)
 ;;=Z52.4^^106^1359^2
 ;;^UTILITY(U,$J,358.3,27440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27440,1,3,0)
 ;;=3^Kidney Donor
 ;;^UTILITY(U,$J,358.3,27440,1,4,0)
 ;;=4^Z52.4
 ;;^UTILITY(U,$J,358.3,27440,2)
 ;;=^5063082
 ;;^UTILITY(U,$J,358.3,27441,0)
 ;;=D47.Z1^^106^1359^9
 ;;^UTILITY(U,$J,358.3,27441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27441,1,3,0)
 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
 ;;^UTILITY(U,$J,358.3,27441,1,4,0)
 ;;=4^D47.Z1
 ;;^UTILITY(U,$J,358.3,27441,2)
 ;;=^5002261
 ;;^UTILITY(U,$J,358.3,27442,0)
 ;;=T86.10^^106^1359^4
 ;;^UTILITY(U,$J,358.3,27442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27442,1,3,0)
 ;;=3^Kidney Transplant Complication,Unspec
 ;;^UTILITY(U,$J,358.3,27442,1,4,0)
 ;;=4^T86.10
 ;;^UTILITY(U,$J,358.3,27442,2)
 ;;=^5055708
 ;;^UTILITY(U,$J,358.3,27443,0)
 ;;=N18.1^^106^1360^1
 ;;^UTILITY(U,$J,358.3,27443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27443,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,27443,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,27443,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,27444,0)
 ;;=N18.2^^106^1360^2
 ;;^UTILITY(U,$J,358.3,27444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27444,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,27444,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,27444,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,27445,0)
 ;;=N18.3^^106^1360^3
 ;;^UTILITY(U,$J,358.3,27445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27445,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,27445,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,27445,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,27446,0)
 ;;=N18.4^^106^1360^4
 ;;^UTILITY(U,$J,358.3,27446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27446,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,27446,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,27446,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,27447,0)
 ;;=N18.5^^106^1360^5
 ;;^UTILITY(U,$J,358.3,27447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27447,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,27447,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,27447,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,27448,0)
 ;;=N18.9^^106^1360^6
 ;;^UTILITY(U,$J,358.3,27448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27448,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,27448,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,27448,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,27449,0)
 ;;=N18.6^^106^1360^7
 ;;^UTILITY(U,$J,358.3,27449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27449,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,27449,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,27449,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,27450,0)
 ;;=N19.^^106^1360^8
 ;;^UTILITY(U,$J,358.3,27450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27450,1,3,0)
 ;;=3^Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,27450,1,4,0)
 ;;=4^N19.
 ;;^UTILITY(U,$J,358.3,27450,2)
 ;;=^5015607
